Biotech/Biomedical
News Category

SS Innovations Promotes Vishwa Srivastava to President, Appoints Gary Lo as CFO
SS Innovations International has promoted Dr. Vishwa Srivastava to president and named Gary Lo chief financial officer as the surgical robotics compan...

Annovis Bio Sets March 2027 Readout for Alzheimer's Drug, Reports Q3 Progress
Annovis Bio's Phase 3 Alzheimer's trial is fully enrolled, with topline data expected in March 2027 and a recent $21 million offering funding operatio...

Vycor Medical Reports Lower Revenue as NovaVision Continues Development
Vycor Medical posted an 18% decline in ViewSite Brain Access System revenue for the third quarter of 2026, which management attributes largely to unus...

Quantum BioPharma Reports $12.22 Million in Cash and Digital Assets, Advances Lucid-MS Phase 2 Trial
Quantum BioPharma's improved liquidity and Phase 2 trial progress for Lucid-MS signal potential advances in multiple sclerosis treatment and strengthe...

OptimumBank Posts 67% EPS Growth as Loans and Deposits Surge in Q3 2026
OptimumBank Holdings reported a 67% year-over-year increase in diluted earnings per share for Q3 2026, driven by strong loan and deposit growth and im...

Oragenics Secures NYSE American Listing Extension Through 2028
Oragenics receives NYSE American compliance extension through February 2028, allowing the clinical-stage biopharmaceutical company to maintain its lis...

Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
Sino Biological's new 4RISE™ services provide rapid wet-lab validation for AI-designed protein binders, delivering AI-ready binding data in as little ...

AI Cuts Echocardiogram Interpretation Time by Half, Matching Human Reports
Artificial intelligence can halve the time cardiologists spend interpreting heart scans while producing reports comparable to human readings, potentia...

Ohio Wastewater Study Links Sewage Bacteria to Community-Wide Health Patterns
A recent Ohio study found that wastewater bacteria can reveal health patterns across entire communities, opening a readily available route for proacti...

Redwood AI Adds Chemical Safety Screening Tool to Reactosphere Platform
Redwood AI Corp. has introduced Chemical AI Risk Evaluator (CARE), a new feature within its Reactosphere platform that helps chemists identify potenti...

HeartBeam Narrows Q3 Loss, Advances Heart Attack Assessment Program
HeartBeam reported a narrower third-quarter net loss and significant progress in its heart attack assessment program, including FDA Breakthrough Devic...

SS Innovations Promotes Vishwa Srivastava to President, Appoints Gary Lo as CFO
SS Innovations International (NASDAQ: SSII) has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as chief financial officer as the co...

SNIP to Bring Physical AI Medical Robotics to MEDICA 2026
Seongnam Industry Promotion Agency and four Korean companies will attend MEDICA 2026 to showcase Physical AI medical robotics and seek international b...

Creative Biolabs Ties AI Antibody Design to Early Developability Decisions
Creative Biolabs is promoting an AI-assisted antibody design and optimization approach that integrates early developability assessment to help biophar...

Novogenia to Provide DNA Analytics and Personalized Supplements for Abu Dhabi GLP-1 Clinical Study
Novogenia AG will contribute DNA analysis and personalized dietary supplements to a planned 500-participant clinical study in Abu Dhabi, aiming to enh...

Earth Science Tech Leverages Vertically Integrated Model to Drive Growth and Profitability
Earth Science Tech Inc. is building a vertically integrated healthcare platform while expanding into real estate, asset management, and consumer produ...

Cardio Diagnostics Whitepaper Highlights Diagnostic Gaps in Non-Obstructive Coronary Artery Disease
Cardio Diagnostics Holdings released a whitepaper on non-obstructive coronary artery disease, emphasizing limitations of invasive angiography and the ...

Preclinical Immunotherapy Eliminates Brain Tumors in Mice, Human Trials Targeted for 2027
UC San Francisco researchers have developed an immunotherapy that wiped out all tumor cells in the brains of treated mice, prompting accelerated plans...

NextPlat Q3 2026: Net Loss Narrows 66%, Gross Margin Expands to 35%
NextPlat Corp. reported a 66% reduction in net loss and gross margin expansion to 35% for Q3 2026, driven by growth in higher-margin pharmacy services...

Resilient Performance Group Flags 'Landing Gap' as Cross-Border Biotech Deals Hit Record Highs
Resilient Performance Group has named the Landing Gap—the unpriced commercial exposure when a drug developed under one regulatory system must launch u...

BioVersys and GSK to Present New Alpibectir Data at The Union World Conference on Lung Health
BioVersys will present Phase 2 data on alpibectir, a novel tuberculosis treatment, at the upcoming Union World Conference, highlighting potential adva...

Quantum BioPharma Shareholders Approve Governance Changes as Insider Voting Control Rises to 68.22%
Quantum BioPharma shareholders approved a 2026 equity plan, potential share consolidation and name change, while a private placement boosted insider v...

UConn Researchers Identify Possible Reason Immunotherapy Fails Some Patients
University of Connecticut researchers have found a potential explanation for why immunotherapy works for some patients but not others, a discovery tha...

Onco-Innovations to Cancel 5.38 Million Shares in Sorbie Funding Termination
Onco-Innovations has agreed to terminate its performance-based funding arrangement with Sorbie, resulting in the cancellation of 5.38 million common s...

Quantum BioPharma Shareholders Approve Sweeping Governance Changes as Insider Voting Power Rises to 68.22%
Quantum BioPharma shareholders approved a potential 10-for-1 share consolidation, a new equity incentive plan and expanded multiple voting share right...

tZERO Secures CFTC Approval for Derivatives Exchange, Hits First Earn-Out Milestone in FG Imperii Merger
tZERO Group, Inc. received CFTC approval to operate a regulated derivatives exchange, completing its DCM and DCO registrations and satisfying the firs...

Creative Biolabs Highlights Three Complementary RNA Profiling Methods to Address Blind Spots in Single-Cell Research
Creative Biolabs is promoting scRNA-seq, snRNA-seq, and smFISH as complementary approaches to overcome limitations in single-cell RNA research, emphas...

Lantern Pharma Publishes Phase 1a Glioblastoma Data, Advances LP-184 Combination Therapy Toward Phase 1b/2a Trial
Lantern Pharma and Starlight Therapeutics published Phase 1a data for LP-184 in recurrent glioblastoma, establishing a recommended dose and supporting...

MIT Researchers Engineer Donor Immune Cells to Wipe Out Cancer Cells
MIT researchers have engineered donor immune cells that nearly eliminated lymphoma in mice within three weeks without rejection, potentially addressin...

NanoViricides Pushes NV-387 Toward Phase II Trials for Measles
NanoViricides is advancing its broad-spectrum antiviral NV-387 into Phase II clinical development for measles, a move that could address a rising unme...

MedRhythms and Vascudyne Take Top Honors at American Heart Association Health Tech Competition
The American Heart Association recognized MedRhythms and Vascudyne as winners of its Health Tech Competition at Scientific Sessions 2026, highlighting...

AI Drafts of Echocardiogram Reports Match Human Accuracy While Cutting Cardiologist Review Time Nearly in Half
A randomized trial presented at the American Heart Association's Scientific Sessions 2026 found AI-generated preliminary echocardiogram interpretation...

Regentis Biomaterials Signs Exclusive Four-Year Distribution Deal for GelrinC in Israel
Regentis Biomaterials has secured a four-year exclusive distribution agreement with AMI Medical Technologies to commercialize its GelrinC knee cartila...

AI Analysis of Smartwatch ECG Data Shows Promise in Detecting Hidden Heart Condition
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 suggests that AI analysis of smartwatch ECG recordings may...

Regentis Biomaterials Signs Four-Year Exclusive Distribution Agreement for GelrinC in Israel
Regentis Biomaterials has secured a four-year exclusive distribution agreement with AMI Medical Technologies to commercialize its GelrinC knee cartila...

Sino Biological Launches 4RISE™ to Validate AI-Designed Molecules
Sino Biological's 4RISE™ platform integrates rapid expression and multi-dimensional validation to accelerate AI-designed molecules from prediction to ...

Tonix Pharmaceuticals Q3 2026 Revenue Jumps to $17.2 Million on TONMYA Growth
Tonix Pharmaceuticals reported Q3 2026 net product revenue of $17.2 million, driven by a 37% sequential increase in TONMYA sales, while advancing its ...

Stocktoberfest 2026 Kicks Off with Howard Lindzon and Barry Ritholtz
Stocktoberfest 2026 programming day opened with a keynote by Howard Lindzon and a fireside chat with Barry Ritholtz, highlighting the value of crowd-s...

Lifordi Presents Phase 1 Data for Subcutaneous Glucocorticoid ADC LFD-200 in Autoimmune Disorders
Lifordi Immunotherapeutics reported Phase 1 data showing its subcutaneous antibody-drug conjugate LFD-200 was well tolerated and reduced inflammation ...

GeoVax Labs Sets 1-for-24 Reverse Stock Split to Regain Nasdaq Compliance
GeoVax Labs will implement a 1-for-24 reverse stock split effective November 11, 2026, to raise its share price above the $1.00 minimum bid required f...

Certified-PEP Launches Wholesale Program to Expand B2B Research Supply
Certified-PEP introduces a wholesale program for qualified laboratories and resellers, offering dedicated accounts, centralized ordering, and access t...

Hong Kong Optical Fair Draws 12,000 Buyers as Smart Eyewear and Silver Economy Reshape Industry
The 34th Hong Kong International Optical Fair concluded with some 12,000 buyers from 101 countries and regions, underscoring Hong Kong's role as a glo...

Sacubitril/Valsartan Combo Reduces AFib Recurrence After Ablation in Hypertensive Patients
A new study presented at the American Heart Association's Scientific Sessions 2026 shows that combining sacubitril and valsartan reduces the recurrenc...

Left Bundle Branch Pacing Cuts Cardiac Events in Heart Block, Trial Shows
A large international trial found that left bundle branch pacing reduced death, heart failure hospitalization, and pacing-induced cardiomyopathy by 59...

Yoga-Based Cardiac Rehab Improves Quality of Life in Heart Failure Patients, But Not Hard Outcomes
A large trial in India found that a yoga-based cardiac rehabilitation program improved quality of life and walking distance for heart failure patients...

Balloon Technique Shows Promise for Improving Circulation During Cardiac Arrest
A preliminary study suggests that using a balloon catheter to block the aorta may improve blood flow to the heart and brain during out-of-hospital car...

Intensive Blood Pressure Therapy Falls Short on Cardiovascular Events in Type 2 Diabetes, but Kidney Risks Rise
A large trial of over 9,000 adults with Type 2 diabetes found that intensive blood pressure treatment below 120 mm Hg did not significantly reduce car...

Stopping Statins for Primary Prevention Generally Safe for Older Adults, But Small Risk Increase Emerges Over Time
New research presented at the American Heart Association's Scientific Sessions 2026 found that discontinuing statins for primary prevention in adults ...